Literature DB >> 16045670

Incontinentia pigmenti case series: clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives.

T A Phan1, O Wargon, A M Turner.   

Abstract

A retrospective case series of 53 female patients with incontinentia pigmenti (IP) including 28 secondary cases (female relatives of probands) was reviewed and compared with other series in an attempt to estimate more accurately the true disease burden of patients with IP. We found that, while the frequency of the first three cutaneous stages of IP was comparable with previous studies, none of the secondary cases manifested any serious neurological complications but all displayed stage IV pale anhidrotic reticulate lines on their posterior calves. This important clinical feature of IP in secondary cases has previously been under-represented in studies that often involved only paediatric probands. Hence, mildly affected cases of IP are often undiagnosed and under-represented in case series to date, possibly leading to inappropriately high estimates of neurological and eye involvement. With the availability of genetic testing, it is now feasible to confirm the variability of the phenotype and the risk of complications in IP.

Entities:  

Mesh:

Year:  2005        PMID: 16045670     DOI: 10.1111/j.1365-2230.2005.01848.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

1.  Long-term follow-up of neurological manifestations in a boy with incontinentia pigmenti.

Authors:  Lucia Margari; Anna Linda Lamanna; Maura Buttiglione; Francesco Craig; Maria G Petruzzelli; Vanessa Terenzio
Journal:  Eur J Pediatr       Date:  2013-05-08       Impact factor: 3.183

Review 2.  Dental and oral anomalies in incontinentia pigmenti: a systematic review.

Authors:  Snežana Minić; Dušan Trpinac; Heinz Gabriel; Martin Gencik; Miljana Obradović
Journal:  Clin Oral Investig       Date:  2012-03-28       Impact factor: 3.573

3.  Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation.

Authors:  Ashley Torkan Zilberstein; Erica L Teng; Anthony J Mancini
Journal:  JAAD Case Rep       Date:  2022-09-21

4.  Incontinentia pigmenti: clinical observation of 40 Korean cases.

Authors:  Beom Joon Kim; Hyo Seung Shin; Chong Hyun Won; Jong Hee Lee; Kyu Han Kim; Myeung Nam Kim; Byung In Ro; Oh Sang Kwon
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

5.  A Multidisciplinary Approach to a Seven Year-Old Patient with Incontinentia Pigmenti: A Case Report and Five-Year Follow Up.

Authors:  Rezvan Rafatjou; Fariborz Vafaee; Hanif Allahbakhshi; Porousha Mahjoub
Journal:  J Dent (Tehran)       Date:  2016-08

6.  Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report.

Authors:  Abduljabbar Alshenqiti; Marwan Nashabat; Hissah AlGhoraibi; Omar Tamimi; Majid Alfadhel
Journal:  Ther Clin Risk Manag       Date:  2017-05-09       Impact factor: 2.423

7.  Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report.

Authors:  S Kunzmann; T Ngyuen; A Stahl; J M Walz; M M Nentwich; C P Speer; K Ruf
Journal:  BMC Pediatr       Date:  2019-10-15       Impact factor: 2.125

8.  Incontinentia pigmenti presenting as hypodontia in a 3-year-old girl: a case report.

Authors:  Dárcio Kitakawa; Patrícia Campos Fontes; Fernando Augusto Cintra Magalhães; Janete Dias Almeida; Luiz Antonio Guimarães Cabral
Journal:  J Med Case Rep       Date:  2009-11-10

9.  Christ Siemens Touraine syndrome: a case report.

Authors:  Luiz Gutenberg Tm Coelho; Arnaldo F Caldas; Evelyne P Soriano; Veronica Ms Rodrigues; Roseane S Costa
Journal:  Cases J       Date:  2009-01-10

Review 10.  Incontinentia pigmenti.

Authors:  Cláudia Schermann Poziomczyk; Júlia Kanaan Recuero; Luana Bringhenti; Fernanda Diffini Santa Maria; Carolina Wiltgen Campos; Giovanni Marcos Travi; André Moraes Freitas; Marcia Angelica Peter Maahs; Paulo Ricardo Gazzola Zen; Marilu Fiegenbaum; Sheila Tamanini de Almeida; Renan Rangel Bonamigo; Ana Elisa Kiszewski Bau
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.